The role of KATP channels in cerebral ischemic stroke and diabetes
V Szeto, N Chen, H Sun, Z Feng - Acta Pharmacologica Sinica, 2018 - nature.com
Abstract ATP-sensitive potassium (K ATP) channels are ubiquitously expressed on the
plasma membrane of cells in multiple organs, including the heart, pancreas and brain. K …
plasma membrane of cells in multiple organs, including the heart, pancreas and brain. K …
Metformin monotherapy for adults with type 2 diabetes mellitus
F Gnesin, ACB Thuesen, LKA Kähler… - Cochrane Database …, 2020 - cochranelibrary.com
Background Worldwide, there is an increasing incidence of type 2 diabetes mellitus (T2DM).
Metformin is still the recommended first‐line glucose‐lowering drug for people with T2DM …
Metformin is still the recommended first‐line glucose‐lowering drug for people with T2DM …
The role of deprescribing in older adults with chronic kidney disease
Older adults with chronic kidney disease (CKD) often experience polypharmacy, a
recognized predictor of prescribing problems including inappropriately dosed medications …
recognized predictor of prescribing problems including inappropriately dosed medications …
Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
R Altara, M Giordano, ES Nordén, A Cataliotti… - Frontiers in …, 2017 - frontiersin.org
Heart failure with preserved ejection fraction (HFpEF) is a major unmet medical need that is
characterized by the presence of multiple cardiovascular and non-cardiovascular …
characterized by the presence of multiple cardiovascular and non-cardiovascular …
Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK
G Liu, K Wu, L Zhang, J Dai, W Huang, L Lin… - International …, 2017 - Elsevier
Metformin is a widely used anti-diabetic drug and increasing evidence suggests that
metformin have profound cardioprotective effects under both diabetic and non-diabetic …
metformin have profound cardioprotective effects under both diabetic and non-diabetic …
Novel applications of metformin in the treatment of septic myocardial injury based on metabolomics and network pharmacology
X Li, Z Zhang, C Li, J Liu, Q Fang, M Zhang… - European Journal of …, 2025 - Elsevier
Background While metformin has shown promise in treating septic myocardial injury (SMI),
its underlying mechanisms and impact on metabolic disturbances remain poorly understood …
its underlying mechanisms and impact on metabolic disturbances remain poorly understood …
[HTML][HTML] Glipizide
R Correa, Q Rodriguez, TM Nappe - 2017 - europepmc.org
Objectives: Identify the mechanism of action of glipizide. Describe the adverse effects of
glipizide. Summarize the appropriate monitoring of glipizide. Explain the importance of …
glipizide. Summarize the appropriate monitoring of glipizide. Explain the importance of …
Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF‑κB signaling pathway Retraction in/10.3892/etm …
H Ma, J Du, X Feng, Y Zhang… - Experimental and …, 2020 - spandidos-publications.com
Influence of rosiglitazone on the myocardial apoptosis in rats with acute myocardial
infarction (AMI) via the Toll‑like receptor 4 (TLR4)/nuclear factor‑κB (NF‑κB) signaling …
infarction (AMI) via the Toll‑like receptor 4 (TLR4)/nuclear factor‑κB (NF‑κB) signaling …
Effect of glipizide on non-insulin-dependent diabetes mellitus
J Yuan - Highlights in Science, Engineering and Technology, 2023 - drpress.org
Type 2 diabetes mellitus, sometimes referred to as non-insulin-dependent
diabetes,(NIDDM). The patient was unable to secrete enough insulin, resulting in elevated …
diabetes,(NIDDM). The patient was unable to secrete enough insulin, resulting in elevated …
Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use
JR Turner - Expert Opinion on Drug Safety, 2017 - Taylor & Francis
Introduction: Cardiovascular safety has become a central component of contemporary drug
development and therapeutic use since noncardiovascular drugs can exert cardiovascular …
development and therapeutic use since noncardiovascular drugs can exert cardiovascular …